Calloway Nathaniel bought LFCR
February 1, 2024 · Form 4 insider transaction
Calloway Nathaniel bought 3,981 shares of Lifecore Biomedical, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,981
Price
N/A
Total value
N/A
InsiderCalloway Nathaniel
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 1, 2024
Filing dateFebruary 2, 2024
Shares owned after28,069
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.